 2. Patients must have progression of disease after radiotherapy including patients that undergo surgery for recurrent disease and are rendered NED. This includes recurrent GBM after receiving all standard first-line treatment, including surgery if feasible due to neurosurgical and neuro-anatomical considerations and adjuvant radiotherapy - chemotherapy. 